Journal of Medical Economics, Volume 22, Issue 10 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 22, Issue 10 (2019)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Volume 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Neurology

Article
An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability
Ghislaine A. van Mastrigt, Silvia M. Evers, Marco Heerings, Leo H. Visser, Rob P. Ruimschotel, Astrid Hussaarts, Lotte Duyverman, Joyce Valkenburg-Vissers, Job Cornelissen, Michel Bos, Maarten van Droffelaar & Peter J. Jongen
Pages: 967-980
Published online: 14 May 2019
AbstractforAn economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability | Full Text | References | PDF (2 MB) | EPUB
  • 1899 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States
Arielle G. Bensimon, Zheng-Yi Zhou, Madeline Jenkins, Yan Song, Wei Gao, James Signorovitch, Clemens Krepler, Frank Xiaoqing Liu, Jingshu Wang & Raquel Aguiar-Ibáñez
Pages: 981-993
Published online: 17 May 2019
AbstractforCost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States | Full Text | References | PDF (1.8 MB) | EPUB
  • 4547 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access

Pharmacoeconomic Trends

Article Commentary
A review of biosimilar in regulations and potential impact: Hong Kong perspectives
Vivian WY Lee & Franco WT Cheng
Pages: 994-996
Published online: 28 May 2019
First Page PreviewforA review of biosimilar in regulations and potential impact: Hong Kong perspectives | Full Text | References | PDF (340 KB) | EPUB
  • 1799 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden
Åsa Ericsson & Adam Fridhammar
Pages: 997-1005
Published online: 23 May 2019
AbstractforCost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden | Full Text | References | PDF (919.6 KB) | EPUB | Supplemental
  • 4070 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study
Gregory F. Guzauskas, Erqi L. Pollom, Volker W. Stieber, Bruce C.M. Wang & Louis P. Garrison Jr
Pages: 1006-1013
Published online: 20 May 2019
AbstractforTumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study | Full Text | References | PDF (1.4 MB) | EPUB
  • 3855 Views
  • 19 CrossRef citations
  • 0Altmetric
Open Access

Hematology

Article
Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP
Joanna Davis, Songkai Yan, Tadashi Matsushita, Lorenzo Alberio, Paul Bassett & Elena Santagostino
Pages: 1014-1021
Published online: 05 Jun 2019
AbstractforSystematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP | Full Text | References | PDF (916 KB) | EPUB
  • 4691 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular Medicine

Letter
Cost of operating room time for endovascular transcatheter aortic valve replacement
Brian J. Potter & Christin Ann Thompson
Pages: 1022-1024
Published online: 25 Jun 2019
AbstractforCost of operating room time for endovascular transcatheter aortic valve replacement | Full Text | References | PDF (435 KB) | EPUB
  • 1302 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Genetic Disease

Article
Characteristics, comorbidities, and use of healthcare resources of patients with phenylketonuria: a population-based study
Josep Darbà
Pages: 1025-1029
Published online: 11 Jul 2019
AbstractforCharacteristics, comorbidities, and use of healthcare resources of patients with phenylketonuria: a population-based study | Full Text | References | PDF (679 KB) | EPUB
  • 935 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Neurology

Article
The real-world economic impact of home-based video electroencephalography: the payer perspective
Jeremy D. Slater, Michael Eaddy, Conor M. Butts, Inna Meltser & Sharanya Murty
Pages: 1030-1040
Published online: 08 Jul 2019
AbstractforThe real-world economic impact of home-based video electroencephalography: the payer perspective | Full Text | References | PDF (962.3 KB) | EPUB | Supplemental
  • 4146 Views
  • 13 CrossRef citations
  • 0Altmetric
Open Access

Economic Evaluations

Article
Willingness to pay for QALY: perspectives and contexts in Japan
Ataru Igarashi, Rei Goto & Mariko Yoneyama-Hirozane
Pages: 1041-1046
Published online: 06 Aug 2019
AbstractforWillingness to pay for QALY: perspectives and contexts in Japan | Full Text | References | PDF (769.7 KB) | EPUB | Supplemental
  • 2973 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access

Respiratory Medicine

Article
A budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt
Gihan Hamdy Elsisi, João Carapinha, Wagdy Amin, Ehab Thabet, Safaa Elafify, Mohamad Amin & Ashraf Hatem
Pages: 1047-1054
Published online: 01 Aug 2019
AbstractforA budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt | Full Text | References | PDF (1.1 MB) | EPUB
  • 1751 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Hematology

Article
Healthcare costs and resource utilization in patients with severe aplastic anemia in the US
Beilei Cai, Qayyim Said, Xin Li, Frank (Yunfeng) Li & Steve Arcona
Pages: 1055-1062
Published online: 04 Aug 2019
AbstractforHealthcare costs and resource utilization in patients with severe aplastic anemia in the US | Full Text | References | PDF (892.9 KB) | EPUB | Supplemental
  • 1433 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular Medicine

Article
Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients: a systematic literature review and network meta-analysis
Vicki Laskier, Holly Guy, Mark Fisher, W. Richey Neuman, Iwona Bucior, Alexander T. Cohen & Shijie Ren
Pages: 1063-1072
Published online: 09 Aug 2019
AbstractforEffectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients: a systematic literature review and network meta-analysis | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 1002 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Addiction Medicine

Article
Modeling the potential impact of abuse-deterrent opioids on medical resource utilization
Mihran A. Yenikomshian, Alan G. White, Michael E. Carson, Zitong B. Jia, Mario R. Mendoza & Carl L. Roland
Pages: 1073-1079
Published online: 13 Aug 2019
AbstractforModeling the potential impact of abuse-deterrent opioids on medical resource utilization | Full Text | References | PDF (606.6 KB) | EPUB
  • 648 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Clinical outcomes associated with pathogenic genomic instability mutations in prostate cancer: a retrospective analysis of US pharmacy and medical claims data
Jinan Liu, Aimee Near, Joseph A. Chiarappa, Keiko Wada, Jenny Tse, Chakkarin Burudpakdee, Ajay Behl, Radhika Ranganath & Emmanuel S. Antonarakis
Pages: 1080-1087
Published online: 28 Aug 2019
AbstractforClinical outcomes associated with pathogenic genomic instability mutations in prostate cancer: a retrospective analysis of US pharmacy and medical claims data | Full Text | References | PDF (1.5 MB) | EPUB
  • 1175 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular Medicine

Article
Economic value and cost-effectiveness of biventricular versus right ventricular pacing: results from the BLOCK-HF study
Eugene S. Chung, Martin G. St. John Sutton, Stuart Mealing, Manpreet K. Sidhu, Amie Padhiar, Stelios I. Tsintzos, Xiaoxiao Lu, Koen J. P. Verhees, Amy A. Lautenbach & Anne B. Curtis
Pages: 1088-1095
Published online: 29 Aug 2019
AbstractforEconomic value and cost-effectiveness of biventricular versus right ventricular pacing: results from the BLOCK-HF study | Full Text | References | PDF (830.9 KB) | EPUB | Supplemental
  • 1349 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Obesity

Article
Ten-year Medicare budget impact of increased coverage for anti-obesity intervention
Fang Chen, Wenqing Su, Abhilasha Ramasamy, Tracy Zvenyach, Scott Kahan, Theodore Kyle & Rahul Ganguly
Pages: 1096-1104
Published online: 19 Aug 2019
AbstractforTen-year Medicare budget impact of increased coverage for anti-obesity intervention | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 2752 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

The efficiency of TAVI in intermediate and low-risk Japanese patients.
Panagiotis Petrou
Editorial | Published online: 25 May 2024
Open Access
Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom
Mafalda Ramos et al.
Article | Published online: 17 May 2024
Open Access
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
John B. Kisiel et al.
Article | Published online: 13 May 2024
Open Access
Balancing innovation and ethics in AI governance for health technology assessment
João L. Carapinha et al.
Editorial | Published online: 13 May 2024
Open Access
View all latest articles